Accredited Activities

An Educational Microlearning Snapshot Activity

Retinal Therapy Revolution: Managing Retinal Disease with Emerging and Targeted Therapies
A Focus on Gene Therapy

This educational Microlearning Snapshot enduring activity focuses on the importance of genes in the pathogenesis of inherited and acquired retinal diseases and how they can be leveraged in gene therapy for the management of various retinal diseases. Additional considerations regarding risk/benefit profile, durability, feasibility and application as well as emerging advances in anti-vascular endothelial growth factor (anti-VEGF) treatment are also explored for impact on overcoming barriers related to treatment burden and adherence.


Vision RELIEF: Navigating Anti-VEGF Treatment Options to Optimize Treatment Individualization

This Immersive Simulation Experience in diabetic retinopathy (DR), neovascular age-related macular degeneration (nAMD) and retinal vein occlusion (RVO) allows learners to engage in clinical decision-making to individualize treatment with anti-vascular endothelial growth factor (anti-VEGF) therapies. By participating in this simulated 3D encounter, you will observe patient-provider interactions and use pertinent information from the patients’ electronic chart to decide the next best course of action at various key points in care, including identifying eyes that may benefit from anti-VEGF treatment, incorporating assessment of efficacy and safety data into treatment decisions, and strategizing changes in treatment approach to achieve optimal outcomes.

Incorporating Clinical Trials Data into the Management of DR, AMD, RVO, mCNV, and PCV

This engaging activity is designed for ophthalmology residents and retina fellows to improve familiarity with new and emerging clinical trial data for retinal vascular diseases. Through better understanding of clinical trial structures, efficacy and safety outcomes for studied anti-VEGF agents, this data can be utilized to enhance the creation of evidence-based treatment plans for patients with DR, AMD, RVO, mCNV, and PCV.


[ai1ec cat_name=”Online Programs” ]



[ai1ec cat_name=”Online Programs” ]


[ai1ec cat_name=”Booth” ]


[ai1ec cat_name=”Grand Rounds” ]
[ai1ec cat_name=”MEDS Meetings” ]

A Virtual Reality Learning Experience: Integrating GLP-1 Receptor Agonists into T2DM Practice—Why, When, and How

[ai1ec cat_name=”NACE Meetings” ]
[ai1ec cat_name=”PriMed Booths” ]

Accreditation Statement
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Scroll to Top

Fellow & Resident Scientific & Educational Resources

The RELIEF Fellow and Resident Toolkit is an online tool that aims to provide up-to-date information on relevant clinical trials in diabetic retinopathy (DR), age-related macular degeneration (AMD), and retinal vein occlusion (RVO). Click on one of the options below to learn more about clinical trials in each disease state.

This activity is provided by Med Learning Group. This activity is co-provided by Ultimate Medical Academy/Complete Conference Management (CCM). This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Copyright © 2019 | Fellow & Resident | All Rights Reserved | Website by Divigner

Welcome to the Fellows Focal Point, a comprehensive clinical resource to provide up-to-date information about relevant clinical trials for various retinal diseases. Thank you for visiting the Fellows Focal Point!

Fellows portal survey questions

For optimized Clinical Trial Tracker use, please utilize Chrome or Firefox browsers